Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer

Tremendous progress has been achieved in the field of immune checkpoint inhibitors (ICIs) therapy in lung cancer in recent years. To generate robust, long-lasting anti-tumor immune responses in lung cancer patients, combinational ICI therapies have been explored deeply. Conventionally, chemotherapy...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Liu, Wei, Zhang, Lei, Xiu, Zhiming, Guo, Jian, Wang, Liye, Zhou, Yue, Jiao, Yang, Sun, Meiyan, Cai, Jianhui
Format: Artigo
Language:Inglês
Published: Dove 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394580/
https://ncbi.nlm.nih.gov/pubmed/32801752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S255491
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items